Keynesonomics
Long

DVAX -Bullish RSI Divergence May Signal an Impending Move Higher

NASDAQ:DVAX   DYNAVAX TECHNOLOGIES CORP
32 0 0
Eddie Gray ( CEO             ) & the rest of Dynavax's "A-Team" are unequivocally committed and, IMO             , well in the process of expanding/creating a diversified PL within a first class biotech franchise. I'm a firm believer that management's rigorous approach to drug development in the field of TLR biology and immune system modulation to attack the challenges of infectious and inflammatory diseases and cancer will extract maximum shareholder value over time; hence, also believe that shares are grossly undervalued at current levels. My LT             PT is actually $62.79 (not shown on this chart) but have provided several reference points (R-1 - R-5) that I think, eventually, will be achieved. Disclosure: Long via common equity. For reference only & not investment advice.
United States
United Kingdom
India
Deutschland
España
France
Việt Nam
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
Malaysia
日本
한국
简体
繁體
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Support Priority Support Report Issue Ideas Published Followers Following Private Messages Chat Sign Out